Cite
HARVARD Citation
Chan‐Tack, K. et al. (2023). Considerations and Challenges in the Remdesivir COVID‐19 Pediatric Development Program. Journal of clinical pharmacology. pp. 259-265. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan‐Tack, K. et al. (2023). Considerations and Challenges in the Remdesivir COVID‐19 Pediatric Development Program. Journal of clinical pharmacology. pp. 259-265. [Online].